President's Perspective
|
AUGS Position Statement on the Restriction of Surgical Options for Pelvic Floor Disorders
Blog: President's Perspective | By: Anthony G Visco, M.D. | Released: Mar 26, 2013 06:04 AM These have certainly been interesting times. Regardless of how one feels regarding the various surgical options for the treatment of pelvic floor disorders, preserving those options and choices for women is our responsibility.... 0 Comment(s) — Latest:None | Average Rating: 5.0/5.0 (1 ratings) Keywords: Announcements | POP | Position statement AUGS Member Code of Conduct
Blog: President's Perspective | By: Anthony G Visco, M.D. | Released: Mar 19, 2013 10:28 AM Our society membership and influence is growing rapidly. As part of this growth, we are continually assessing and updating our governance structure, policies and procedures.... 0 Comment(s) — Latest:None | Average Rating: 5.0/5.0 (1 ratings) Keywords: Announcements AUGS Releases Guidelines for Privileging and Credentialing Physicians for Sacrocolpopexy for POP
Blog: President's Perspective | By: Anthony G Visco, M.D. | Released: Feb 27, 2013 11:14 AM AUGS is pleased to announce the release of Guidelines for Privileging and Credentialing Physicians for Sacrocolpopexy for Pelvic Organ Prolapse (POP). ... 0 Comment(s) — Latest:None | Average Rating: 0.0/5.0 (0 ratings) Keywords: Announcements | Guidelines 1st AUGS/SUFU FPMRS Review Course Off to a Great Start!
Blog: President's Perspective | By: Anthony G Visco, M.D. | Released: Feb 03, 2013 07:37 AM On Friday, February 1, we launched the first of two comprehensive review courses this year. Please see the below photo of the (happy) attendees that exceeded 440 for this initial course.The course was designed to follow the published ABOG/ABU Guide to Learning Objectives.... 2 Comment(s) — Latest:Feb 05, 2013 05:49 AM | Average Rating: 0.0/5.0 (0 ratings) Keywords: Announcements | review course Even more options for women with OAB (Oxytrol - OTC)
Blog: President's Perspective | By: Anthony G Visco, M.D. | Released: Jan 27, 2013 06:56 PM Until recently, there was no Over-The-Counter (OTC) anticholinergic option for women with Overactive Bladder. That is no longer the case. The FDA has approved the switch of Oxytrol, a transdermal form of oxybutynin, from prescription to Over-The-Counter (OTC). ... 0 Comment(s) — Latest:None | Average Rating: 0.0/5.0 (0 ratings) Keywords: Announcements | FDA | OAB | Urinary Incontinence |
